Integrating New Therapies Into the Management of Relapsed/Refractory Myeloma: Experts Address the Paradox of Choice

Download All
Hear from experts how the latest data from ASCO 2021 inform therapeutic strategies for patients with R/R MM and how to evaluate novel combination therapeutic regimens. Review their insights in clinical commentaries, slides, a podcast, and an on-demand webcast from a live CCO webinar.
Paul G. Richardson, MD
Program Director
Paul G. Richardson, MD
Nina Shah, MD
Peter M. Voorhees, MD

Podcast

Listen to Paul G. Richardson, MD; Nina Shah, MD; and Peter M. Voorhees, MD, as they answer audience questions from a live webinar about how to best use the plethora of active agents and regimens now available for patients with advanced multiple myeloma.

Paul G. Richardson, MD
Program Director
Nina Shah, MD Peter M. Voorhees, MD
Released: August 24, 2021

Download this short summary of key takeaways from a podcast on managing patients with R/R MM including expert recommendations on selecting optimal therapy.

Paul G. Richardson, MD Nina Shah, MD Peter M. Voorhees, MD Released: August 25, 2021
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Bristol-Myers Squibb
GlaxoSmithKline
Karyopharm
Oncopeptides
Sanofi Genzyme

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings